Maternal-Fetal Medicine (MFM) Qualifying Practice Exam 2026 – Your All-in-One Guide to Mastering the MFM Certification!

Glyburide is classified as a sulfonylurea, which is a type of medication used primarily to manage blood glucose levels in individuals with type 2 diabetes. Sulfonylureas function by stimulating the pancreatic beta cells to release more insulin, thereby reducing blood sugar levels after meals.

This class of medications is characterized by their ability to enhance insulin secretion, and they play a significant role in the treatment of diabetes. Glyburide specifically is known for its relatively quick onset of action and duration, which can benefit patients needing more controlled blood sugar management.

Other drug classes listed in the options have different mechanisms of action and indications. For example, biguanides, such as metformin, primarily work by decreasing hepatic glucose production and increasing insulin sensitivity but do not stimulate insulin secretion directly. Thiazolidinediones, like pioglitazone, act by enhancing insulin sensitivity in muscle and fat tissues but do not affect insulin secretion from the pancreas. DPP-4 inhibitors, such as sitagliptin, facilitate incretin hormones which aid in insulin secretion but do not belong to the sulfonylurea class.

Understanding this classification helps clarify the pharmacological approach taken for glucose control and the role of various diabetes medications in treatment